Similar articles

• [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].

  Franz N, Modersohn D, Linss G, Heublein B, Gola G, Bruch L, Walde T. Franz N, et al. Radiol Diagn (Berl). 1990;31(6):625-8. Radiol Diagn (Berl). 1990. PMID: 1982742 German.
• Celiprolol in angina pectoris.

  Soberman JE, Frishman WH. Soberman JE, et al. Am Heart J. 1988 Nov;116(5 Pt 2):1422-5. doi: 10.1016/0002-8703(88)90134-2. Am Heart J. 1988. PMID: 2903653 Review.
• Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.

  Milne RJ, Buckley MM. Milne RJ, et al. Drugs. 1991 Jun;41(6):941-69. doi: 10.2165/00003495-199141060-00009. Drugs. 1991. PMID: 1715268 Review.
• Celiprolol--overview of 6 years of clinical trials experience.

  Pruss TP, Lamon KD, Hagen NS. Pruss TP, et al. J Int Med Res. 1988;16 Suppl 1:17A-22A. J Int Med Res. 1988. PMID: 2906015 Clinical Trial.
• A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.

  Harston WE, Eff J, Capone P. Harston WE, et al. Br J Clin Pract Suppl. 1985 Jun;40:55-8. Br J Clin Pract Suppl. 1985. PMID: 2864066 Clinical Trial. No abstract available.